Abstract

Peroxisome proliferators (PPs) are an important group of chemicals that include certain hypolipidemic drugs, plasticizers and pollutants. Chemicals that are classified as PPs are known rodent liver tumor promoters, although there is debate whether humans are at increased cancer risk upon exposure. The effects observed upon long-term treatment of rodents to PPs include hepatic peroxisome proliferation, hepatomegaly, regulation of gene expression, alteration in cell cycle control and ultimately, carcinogenesis. The majority of the physiological, toxicological and carcinogenic effects induced by PPs are mediated by a nuclear hormone receptor, Peroxisome Proliferator-Activated Receptor-α (PPARα). Although humans respond to PPs via PPARα activation resulting in altered lipid metabolism, there is little evidence for peroxisome proliferation or liver cancer. In the present chapter, the current understanding of how PPARs are involved in tumorigenesis, and what this may mean to human risk assessment, will be discussed.

Original languageEnglish (US)
Title of host publicationGeneral, Applied and Systems Toxicology
Subtitle of host publicationBallantyne/Toxicology
Publisherwiley
Pages1-12
Number of pages12
ISBN (Electronic)9780470744307
ISBN (Print)9780470723272
DOIs
StatePublished - Jan 1 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • General Chemistry
  • General Chemical Engineering

Fingerprint

Dive into the research topics of 'Toxicity of Peroxisome Proliferators'. Together they form a unique fingerprint.

Cite this